TGA
MR

Trilogy Global Advisors’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

Trilogy Global Advisors’s Portfolio MR Stock Details MR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-1,835,738
Closed -$57.8M – 91
2014
Q2 		$57.8M Sell
1,835,738
-1,293,210
-41% -$41M 1.1% 41
2014
Q1 		$101M Buy
3,128,948
+544,274
+21% +$19.1M 2.03% 16
2013
Q4 		$94M Sell
2,584,674
-122,445
-5% -$4.76M 1.92% 13
2013
Q3 		$105M Buy
2,707,119
+109,999
+4% +$4.43M 2.27% 10
2013
Q2 		$97.3M Buy
+2,597,120
New +$103M 2.26% 8

Other funds holding MR

Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
GAM
Genesis Asset Managers Guernsey, Channel Islands, United Kingdom $3.53B AUM 1.54% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Trilogy Global Advisors's MR Position: Q3 2014 in Review

Trilogy Global Advisors sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q3 2014, closing a stake of 1,835,738 shares — an estimated $57.8M sold.

Trilogy Global Advisors first reported a position in MR in Q2 2013 and held it in 5 quarters. The position peaked at $105M in Q3 2013. 129 funds tracked by Wall St. Rank hold MR as of Q3 2014.

  • Trilogy Global Advisors reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q3 2014 after selling out during the quarter.
  • Trilogy Global Advisors sold 1,835,738 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q3 2014, an estimated $57.8M.
  • Trilogy Global Advisors first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q2 2013 and held it in 5 quarters.
  • Trilogy Global Advisors's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $105M in Q3 2013.
  • 129 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q3 2014.

Based on Trilogy Global Advisors's 13F filing for Q3 2014, filed 12 Nov 2014.